Pharma Reimbursement & Market Access 2015

Key Topics

• How to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
• When, where and how Comparative Effectiveness Research should be factored into a drug manufacturers overall market access strategy
• Key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
• How to use HTA to create payer evidence: The role of postapproval programs
• Insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
• The evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
• The current state of affairs: Post midterm elections in the exchange marketplaceand the impact on drug positioning
• Anticipate the implementation of ICD-10 and the underlying effect on product
• Your engagement model: The new look of pharma/ biopharma/payer relationship

Who should Attend

Attendees from:

• Outcome Research
• Health Economics
• Effectiveness Research
• Comparative
• Brand Access
• Pricing
• Commercialization
• Market Access
• Outcomes
• Payer Relationships
• Marketing Commercialization
• Patient-Reported Outcomes
• Outcomes, Liaison, Access Solutions